Sun Pharma to offer cheaper medicines in US under deal with Trump
- Sun Pharma signs a deal with the US government to offer cheaper medicines to American patients.
- Sun Pharma will offer its medicines at lower prices to US Medicaid programmes.
- The pricing commitment will also cover Sun Pharma’s future innovative medicine launches in the US.
- In return, the US will delay Section 232 tariffs on Sun Pharma’s innovative medicines for over two years.
Source: hindustantimes.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
